Estimated value of the amount of financing transferred as part of the Demerger
13.04.2026
See also
Synektik plans to devide. It is spinning off the cardiotracer research project into a new company which will also be listed on the WSE
- Corporate news
- Investor relations
Synektik one step closer to planned division
- Corporate news
- Investor relations
KNF has approved the Syn2bio prospectus. The debut on the WSE is planned for April
- Corporate news
- Investor relations